Research ArticleCancer

ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma

See allHide authors and affiliations

Science Translational Medicine  20 Jan 2021:
Vol. 13, Issue 577, eabc0170
DOI: 10.1126/scitranslmed.abc0170

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article